Senate Committee Passes Bipartisan FDA Reauthorization Bill
A Senate Committee has passed a bipartisan FDA reauthorization bill that includes several provisions aimed at improving drug safety, bringing breakthrough treatments to patients more quickly, advancing medical device innovations and preventing critical drug shortages.
Read the full report in Becker's Hospital Review on the FDA reauthorization bill.
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.